If youd like to speak with someone who specializes in obesity medicine, you can input your city to see a list of providers who are credentialed by the American Board of Obesity Medicine.
February 3, 2026: Man Sues Ozempic, Claims the Injectable Semaglutide Caused Him to Lose Sight A man from Ohio has filed a legal claim against Ozempics manufacturer, Novo Nordisk, alleging that he developed NAION after taking Ozempic as prescribed
Police in Santa Rosa, CA seized a pill press while executing a search warrant
Today, we shall journey through the multifaceted landscape of AOD 9604, critically assessing its credentials in the weight loss context
It mimics the hormone GLP-1 to stimulate insulin production, slow gastric emptying, and reduce appetite